91 related articles for article (PubMed ID: 15613458)
1. BRAF and endocrine tumors: mutations are frequent in papillary thyroid carcinomas, rare in endocrine tumors of the gastrointestinal tract and not detected in other endocrine tumors.
Perren A; Schmid S; Locher T; Saremaslani P; Bonvin C; Heitz PU; Komminoth P
Endocr Relat Cancer; 2004 Dec; 11(4):855-60. PubMed ID: 15613458
[TBL] [Abstract][Full Text] [Related]
2. Genetic mutations in thyroid carcinoma.
Taccaliti A; Boscaro M
Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
[TBL] [Abstract][Full Text] [Related]
3. No evidence for mutation of B-RAF in urothelial carcinomas of the bladder and upper urinary tract.
Stoehr R; Brinkmann A; Filbeck T; Gamper C; Wild P; Blaszyk H; Hofstaedter F; Knuechel R; Hartmann A
Oncol Rep; 2004 Jan; 11(1):137-41. PubMed ID: 14654916
[TBL] [Abstract][Full Text] [Related]
4. Mitogen-activated protein kinase signaling is activated in prostate tumors but not mediated by B-RAF mutations.
Burger M; Denzinger S; Hammerschmied C; Tannapfel A; Maderstorfer A; Wieland WF; Hartmann A; Stoehr R
Eur Urol; 2006 Nov; 50(5):1102-9; discussion 1109-10. PubMed ID: 16413100
[TBL] [Abstract][Full Text] [Related]
5. Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis.
Willmore-Payne C; Holden JA; Tripp S; Layfield LJ
Hum Pathol; 2005 May; 36(5):486-93. PubMed ID: 15948115
[TBL] [Abstract][Full Text] [Related]
6. Identification of borderline thyroid tumors by gene expression array analysis.
Arora N; Scognamiglio T; Lubitz CC; Moo TA; Kato MA; Zhu B; Zarnegar R; Chen YT; Fahey TJ
Cancer; 2009 Dec; 115(23):5421-31. PubMed ID: 19658182
[TBL] [Abstract][Full Text] [Related]
7. Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells.
Mitsutake N; Knauf JA; Mitsutake S; Mesa C; Zhang L; Fagin JA
Cancer Res; 2005 Mar; 65(6):2465-73. PubMed ID: 15781663
[TBL] [Abstract][Full Text] [Related]
8. Suppression of BRAF/MEK/MAP kinase pathway restores expression of iodide-metabolizing genes in thyroid cells expressing the V600E BRAF mutant.
Liu D; Hu S; Hou P; Jiang D; Condouris S; Xing M
Clin Cancer Res; 2007 Feb; 13(4):1341-9. PubMed ID: 17317846
[TBL] [Abstract][Full Text] [Related]
9. Novel mutations of the MET proto-oncogene in papillary renal carcinomas.
Schmidt L; Junker K; Nakaigawa N; Kinjerski T; Weirich G; Miller M; Lubensky I; Neumann HP; Brauch H; Decker J; Vocke C; Brown JA; Jenkins R; Richard S; Bergerheim U; Gerrard B; Dean M; Linehan WM; Zbar B
Oncogene; 1999 Apr; 18(14):2343-50. PubMed ID: 10327054
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial DNA alterations in thyroid cancer.
Tong BC; Ha PK; Dhir K; Xing M; Westra WH; Sidransky D; Califano JA
J Surg Oncol; 2003 Mar; 82(3):170-3. PubMed ID: 12619060
[TBL] [Abstract][Full Text] [Related]
11. Mutation analysis of the BRAF codon 599 in malignant pleural mesothelioma by enriched PCR-RFLP.
Dote H; Tsukuda K; Toyooka S; Yano M; Pass HI; Shimizu N
Oncol Rep; 2004 Feb; 11(2):361-3. PubMed ID: 14719068
[TBL] [Abstract][Full Text] [Related]
12. PTEN promoter methylation in sporadic thyroid carcinomas.
Alvarez-Nuñez F; Bussaglia E; Mauricio D; Ybarra J; Vilar M; Lerma E; de Leiva A; Matias-Guiu X;
Thyroid; 2006 Jan; 16(1):17-23. PubMed ID: 16487009
[TBL] [Abstract][Full Text] [Related]
13. Expression of intermediate filaments in neuroendocrine tumors.
Kimura N; Nakazato Y; Nagura H; Sasano N
Arch Pathol Lab Med; 1990 May; 114(5):506-10. PubMed ID: 2159272
[TBL] [Abstract][Full Text] [Related]
14. Reply to: Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas.
Lima J; Trovisco V; Soares P; Máximo V; Magalhães J; Salvatore G; Santoro M; Bogdanova T; Tronko M; Abrosimov A; Jeremiah S; Thomas G; Williams D; Sobrinho-Simões M
Cancer Lett; 2005 Dec; 230(1):149-50. PubMed ID: 16253771
[No Abstract] [Full Text] [Related]
15. [Classification and epidemiology of thyroid tumors].
Klein M; Aubert V; Weryha G; Leclère J
Rev Prat; 1996 Dec; 46(19):2288-95. PubMed ID: 8978185
[TBL] [Abstract][Full Text] [Related]
16. High incidence of thyroid cancer in long-standing goiters with thyroglobulin mutations.
Hishinuma A; Fukata S; Kakudo K; Murata Y; Ieiri T
Thyroid; 2005 Sep; 15(9):1079-84. PubMed ID: 16187918
[TBL] [Abstract][Full Text] [Related]
17. The V599E BRAF mutation is uncommon in biliary tract cancers.
Goldenberg D; Rosenbaum E; Argani P; Wistuba II; Sidransky D; Thuluvath PJ; Hidalgo M; Califano J; Maitra A
Mod Pathol; 2004 Nov; 17(11):1386-91. PubMed ID: 15181454
[TBL] [Abstract][Full Text] [Related]
18. A study of gata3 and phox2b expression in tumors of the autonomic nervous system.
Nonaka D; Wang BY; Edmondson D; Beckett E; Sun CC
Am J Surg Pathol; 2013 Aug; 37(8):1236-41. PubMed ID: 23715162
[TBL] [Abstract][Full Text] [Related]
19. ras mutations in follicular variant of papillary thyroid carcinoma.
De Micco C
Am J Clin Pathol; 2003 Nov; 120(5):803; author reply 804. PubMed ID: 14608909
[No Abstract] [Full Text] [Related]
20. Identification, characterization and classification of endocrine tumours.
Wilander E; Grimelius L
Zentralbl Pathol; 1993 Jun; 139(2):95-100. PubMed ID: 7690247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
